Genkomax Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 16-12-2024
- Paid Up Capital ₹ 1.50 M
as on 16-12-2024
- Company Age 15 Year, 3 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 9.98%
(FY 2020)
- Profit 54.60%
(FY 2020)
- Ebitda 58.14%
(FY 2020)
- Net Worth -454.79%
(FY 2020)
- Total Assets 8.05%
(FY 2020)
About Genkomax Sciences
The Corporate was formerly known as Galelead Sciences Private Limited. The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Ritesh Ranjan, Vijay Kumar, and Lalit Kumar serve as directors at the Company.
- CIN/LLPIN
U24232BR2009PTC014839
- Company No.
014839
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Sep 2009
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Genkomax Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ritesh Ranjan  | Director | 14-Sep-2009 | Current |
| Vijay Kumar | Director | 31-Dec-2009 | Current |
| Lalit Kumar | Director | 26-Feb-2015 | Current |
Financial Performance of Genkomax Sciences.
Genkomax Sciences Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 9.98% increase. The company also saw a substantial improvement in profitability, with a 54.6% increase in profit. The company's net worth observed a substantial decline by a decrease of 454.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genkomax Sciences?
In 2016, Genkomax Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Genkomax Sciences?
Genkomax Sciences has a workforce of 27 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genkomax Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genkomax Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
